In the pharmaceutical industry, about one-third of all drugs in the pipeline of the top ten pharmaceutical companies were initially developed elsewhere. Sponsor companies have continued their push to lower their operating costs while leveraging expertise to help manage growth in drug development pipelines. Tahseen Khan, senior writer on Drug Development clarifies the key influence factors and strategies in global outsourcing and vendor management.